Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2023-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for an upcoming General Meeting. It contains details about the meeting agenda (approval of financial statements, election of directors/auditors, remuneration limits, and articles of incorporation changes), information about the solicitors, and the proxy solicitation process. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의), which includes the agenda, proposed resolutions (such as director/auditor re-election, financial statement approval, and business purpose changes), and meeting logistics. This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2023-03-02 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2023-03-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (Annual General Meeting). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding meeting logistics, it falls under the general regulatory filing category.
2022-12-14 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short, structured announcement reporting the results of an Investor Relations (IR) event held by the company. It lists the date, location, attendees, and agenda of the meeting. Since it is a brief notification summarizing the occurrence of an event rather than the full presentation deck or a comprehensive financial report, it falls under the category of a regulatory announcement regarding corporate activities.
2022-10-27 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since this is an announcement of an upcoming event rather than the presentation materials themselves or a transcript of the event, it falls under the category of a regulatory announcement regarding corporate activities.
2022-10-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.